Morgan Stanley

Key Findings

• Economic: Morgan Stanley & Co. LLC underwrote part of Elbit Systems’ May 2025 primary equity offering, with an initial allocation of 273,090 shares. The completed syndicate-wide offering generated approximately $588.8 million in gross proceeds for Elbit; Morgan Stanley’s allocation of the additional shares was not established.^{1, 2, 3}
• Economic: Morgan Stanley & Co. International plc participated in Bank Hapoalim’s January 2026 $2 billion bond offering. Morgan Stanley’s admission to Israel’s sovereign-bond primary-dealer programme was announced in May 2026, although actual trading commencement remained unverified.^{4, 5, 6}
• Political: IRS-derived records report a fiscal-year 2024 grant of $1,739,995 to Friends of the Israel Defense Forces by Morgan Stanley Global Impact Funding Trust. The legally distinct donor-advised charitable trust’s payment was not established as a donation from Morgan Stanley corporate funds or a corporate endorsement.^{7, 8, 9, 10}
• Not found: No public evidence identified of direct Morgan Stanley weapons supply, Israeli military technology contracts, Project Nimbus participation or a company-operated settlement facility. Documented defence financing and commercial technology investments must be distinguished from those unsupported operational claims.^{11, 1, 12, 13, 14}

Target Profile

Executive Summary

Morgan Stanley’s documented Israel/Palestine nexus principally concerns financial intermediation. The firm has a long-standing Israeli investment-banking presence, with October 2026 reporting tracing local business activity to the 1990s and a formal office presence to approximately 2000. Co-president Daniel Simkowitz described relationships with Israeli technology companies and transactions involving Mobileye, SentinelOne, Wiz and Armis. These records establish commercial activity and executive engagement; they do not establish military technology procurement by Morgan Stanley.¹⁷

The strongest direct capital-raising evidence is Morgan Stanley & Co. LLC’s participation in Elbit Systems’ May 2025 primary equity offering. Its initial contractual allocation was 273,090 newly issued shares, approximately $102.41 million at the public offering price or $100.39 million at the underwriters’ purchase price. The completed offering, including the syndicate’s fully exercised additional-share option, generated approximately $588.8 million in gross proceeds for Elbit. Proceeds were designated for general corporate purposes, without a specified weapons programme. This completed primary financing is distinct from Morgan Stanley’s separately reported institutional Elbit holdings.^{1, 2, 3, 18}

Other substantial economic relationships include Morgan Stanley & Co. International plc’s participation in Bank Hapoalim’s January 2026 $2 billion bond issuance and the announced May 2026 admission of Morgan Stanley to Israel’s sovereign-bond primary-dealer programme. The latter was intended to support government-debt-market liquidity and financing conditions, but operational commencement remained conditional on required procedures in the reviewed announcement. Commercial technology exposure includes participation in groundcover’s July 2026 $100 million financing round; Morgan Stanley’s individual investment amount and ownership percentage were not established.^{4, 5, 6, 19}

The political record includes human-rights scrutiny of defence investment relationships and a separately attributable charitable-trust grant. The Business & Human Rights Resource Centre recorded no Morgan Stanley response to its July 2024 outreach. IRS-derived records report a $1,739,995 FIDF grant by MS GIFT during fiscal year 2024, but do not establish corporate funding or corporate selection of that recipient. No public evidence identified of direct weapons delivery, military digital services, verified settlement premises or Israel-specific lobbying for settlement expansion. The fixed, human-vetted V6.6 result is BRS 667, Tier B (Severe Complicity), driven by Economic; this research classification is not a judicial determination.^{20, 7, 8, 9, 10, 11, 15, 12, 13, 14}

Timeline of Relevant Events

Corporate Overview

Morgan Stanley is a US financial-services parent with institutional securities, wealth-management and investment-management businesses. Its significant-subsidiary schedule identifies Morgan Stanley & Co. LLC, Morgan Stanley & Co. International plc, Morgan Stanley Bank, N.A., Morgan Stanley Investment Management Inc. and Morgan Stanley International Limited, among others. The schedule expressly omits certain entities under SEC significance rules and is not an exhaustive ownership chart.^{11, 13}

Entity attribution matters. Morgan Stanley & Co. LLC signed the Elbit underwriting agreement; Morgan Stanley & Co. International plc participated in the Bank Hapoalim offering; Morgan Stanley Expansion Capital participated in groundcover’s financing. Morgan Stanley Institutional Fund’s Global Insight Portfolio separately reported an Oddity Tech holding. These activities cannot all be described as investments from the parent company’s corporate treasury.^{1, 4, 19, 26}

The audits identify Morgan Stanley Israel Limited through historical office information and corroboration of an Israeli workforce, while noting that the reviewed significant-subsidiary exhibit did not independently establish its complete ownership chain. No public evidence identified of an Israeli franchise arrangement, settlement branch or company-operated facility in the occupied West Bank or East Jerusalem. The corporate records establish New York headquarters and US incorporation, rather than an Israeli founding or management domicile.^{11, 17, 13, 22, 14}

MUFG’s approximately 24% stake and director-designation rights establish a significant shareholder relationship. They do not make unrelated MUFG transactions Morgan Stanley acts. Likewise, directors’ separate Boeing, Caterpillar or cybersecurity affiliations require transaction-specific evidence before attribution to Morgan Stanley.^{15, 16}

Domain Summaries

Military: Military

Mechanism of Involvement

The documented defence nexus is financial. Morgan Stanley & Co. LLC’s May 2025 Elbit underwriting provided primary-market capital to an Israeli defence manufacturer. Schedule A allocated it 273,090 initial shares, 20% of the initial offering, at a $375 public offering price and $367.61 contractual purchase price. Underwriters’ obligations were several rather than joint; the approximately $588.8 million completed offering total therefore must not be presented as Morgan Stanley’s individual contribution.^{1, 2, 3}

Elbit expected approximately $575 million in net proceeds after full exercise of the option and estimated costs. Subsequent financial statements recorded $573.0 million in share-issuance cash inflows. These records establish capital received, but do not trace specific expenditure or weapons production to Morgan Stanley’s participation. The reviewed completion records identify no outstanding additional-share obligation or continuing underwriting commitment.^{2, 3}

Separately, SEC-derived holdings history records continued institutional Elbit exposure through June 2026. September 2024 UN mandate holders also named Morgan Stanley & Co. LLC among financial institutions reportedly investing in defence manufacturers exporting weapons to Israel. That communication did not provide a complete institution-by-manufacturer transaction matrix, Morgan Stanley-specific financing amounts or individual military contracts.^{18, 23}

Counter-Arguments and Evidence Limits

Morgan Stanley’s strongest defence is that the documented conduct consists of financial services, with no verified direct weapons supply. No public evidence identified of Morgan Stanley manufacturing weapons, supplying components, maintaining military platforms, operating military logistics or holding a direct Israeli security-force procurement contract. The underwriting documents also do not earmark proceeds for a particular military operation or weapons system.^{11, 1, 2, 23}

Reported securities holdings do not independently establish proprietary ownership, direct issuer financing or discretionary investment selection. Holdings existed before the May 2025 offering, and quarterly snapshots cannot identify whether particular shares came from that transaction. Separate Boeing and Caterpillar board affiliations do not establish Morgan Stanley control over those companies’ military sales. The UN communication is human-rights scrutiny, not an adjudicated export-control violation.^{15, 18, 23}

The fixed Military score remains 0.00. The financial relationships are preserved in the evidence record and economic assessment without recasting them as direct military supply.

Named Entities and Evidence Map

Digital: Digital

Mechanism of Involvement

Morgan Stanley Expansion Capital participated in groundcover’s July 2026 $100 million Series C. The company provides commercial cloud observability and application-monitoring technology. The financing establishes investment exposure to an Israeli technology business, rather than a disclosed Morgan Stanley procurement contract or military deployment. Morgan Stanley’s individual contribution, ownership percentage and voting rights remained unestablished.^{19, 27}

Morgan Stanley’s documented internal technology relationships include its Microsoft cloud partnership and OpenAI-powered financial-adviser applications. The latter support information retrieval and consent-based meeting summarisation, client notes and draft follow-ups. These are documented financial-services productivity workflows.^{21, 28}

Counter-Arguments and Evidence Limits

The strongest defence is the civilian character and direction of the documented relationships. Morgan Stanley is an enterprise technology customer and a commercial technology investor; those roles do not establish that it supplies digital capabilities to Israeli security bodies. No public evidence identified of a direct Israeli military technology contract, offensive cyber product, biometric-surveillance deployment or military targeting system supplied by Morgan Stanley.^{19, 21, 28}

Israel’s Nimbus procurement record names AWS and Google as selected public-cloud providers. No public evidence identified of Morgan Stanley participation, subcontracting or integration. No public evidence identified establishing Israeli hosting of its principal customer-data repositories or transfer of identifiable client information into Israeli jurisdiction. An unverified data-retention arrangement cannot be converted into evidence of Israeli data processing.^{12, 28}

No public evidence identified connecting groundcover investment to a military or settlement installation. Glocer’s separately documented cybersecurity ventures do not establish a Morgan Stanley contract with those businesses or provision of offensive cyber tools to Israel. Digital remains 0.00.^{19, 27, 29}

Named Entities and Evidence Map

Economic: Economic

Mechanism of Involvement

Economic contains the strongest documented nexus: direct capital-market services, announced sovereign-debt infrastructure participation and continuing reported investment exposure. Elbit’s completed primary equity offering provided issuer capital, while Bank Hapoalim’s January 2026 transaction raised $2 billion through a syndicate including Morgan Stanley & Co. International plc. Bank Hapoalim’s stated purposes were general corporate funding and diversification; Morgan Stanley’s individual allocation, fees and profit were not disclosed.^{1, 2, 3, 4, 5}

The May 2026 primary-dealer announcement described a formal relationship with Israel’s government-securities market. Primary dealers participate in issuance and secondary-market activity under arrangements with the Accountant General. The stated objectives included broader investor participation, greater liquidity and lower financing costs. Actual Morgan Stanley trading commencement and volumes remained unverified.⁶

The latest ascertainable Elbit quarter-end position was 169,101 shares valued at $128,301,694 on 30 June 2026, compared with 164,226 shares valued at $139,444,960 in March. It represented less than 0.01% of Morgan Stanley’s reported 13F portfolio. The record establishes continued reported exposure, while leaving proprietary ownership, client mandates and investment strategy unresolved.¹⁸

Additional commercial exposure includes the reported November 2024 Capitolis investment, groundcover financing, the Global Insight Portfolio’s approximately $74,000 Oddity Tech holding in March 2026, and long-standing Israeli advisory activity. These are distinct mechanisms with different funding and attribution limits.^{17, 19, 24, 26}

Counter-Arguments and Evidence Limits

The strongest defence is that these are ordinary financial-services relationships whose downstream uses are incompletely traced. Elbit underwriting was completed in May 2025; continuing issuer balance-sheet effects do not establish an ongoing Morgan Stanley financing obligation. No public evidence identified of retained underwriting inventory, unsold allocations or an outstanding purchase commitment attributable to that offering.^{1, 3, 18}

The holdings record establishes neither an entirely passive portfolio nor an actively selected material allocation under a named discretionary strategy. Voting authority does not resolve those questions. The reported Oddity position belongs to a managed fund, and groundcover’s acquisition of Wand does not establish Morgan Stanley control of either company.^{18, 25, 26}

Exclusions are material. Morgan Stanley was not named among the five bookrunners of Israel’s February 2025 $5 billion sovereign offering, and the cited BankTrack investigation did not establish its participation in the sovereign transactions examined. No public evidence identified of a specific settlement-project loan, named settlement-enterprise financial product, settlement office, Israeli agricultural sourcing programme or current Samanage ownership.^{30, 31, 11, 19, 13, 14}

Named Entities and Evidence Map

Political: Political

Mechanism of Involvement

The political record combines documented scrutiny, state-financing relationships and a carefully bounded charitable-trust finding. The Business & Human Rights Resource Centre invited Morgan Stanley to respond on 3 July 2024 to concerns following UN experts’ arms-investment appeal. Its company-specific page recorded no response as of 12 July. This is a dated public response record, not proof that no subsequent private correspondence occurred.²⁰

MS GIFT, EIN 52-7082731, reportedly paid FIDF $1,739,995 during fiscal year 2024 for “UNRESTRICTED GENERAL SUPPORT.” OpenGrants and InfluenceWatch reproduce the IRS-derived grant information, while ProPublica confirms the trust’s filing and donor-advised-fund status. The original Schedule I row could not be independently inspected during the audit because direct downloads returned access errors.^{7, 8, 9}

MS GIFT’s guidelines describe donor recommendations followed by trust review and approval. Donated assets become trust property, and unrestricted recipients retain spending discretion. Morgan Stanley Smith Barney LLC provides investment-management services; RenPSG is identified as an unaffiliated administrator. These arrangements establish the trust’s framework without identifying the recommending donor or specific approval deliberations for FIDF.¹⁰

Counter-Arguments and Evidence Limits

The strongest defence is entity and funding attribution. No public evidence identified establishing that the FIDF grant originated from Morgan Stanley corporate funds, its charitable budget or a corporate recipient-selection decision. It must remain a grant by the legally distinct MS GIFT, without being presented as verified corporate endorsement.^{7, 9, 10}

No public evidence identified of verified Morgan Stanley corporate endorsement of Israeli military operations, Israel-specific settlement-expansion lobbying, anti-BDS lobbying, punitive treatment of pro-Palestinian employees or military-reservist salary subsidies beyond applicable obligations. General political-activity oversight disclosures do not establish those acts, and nonresponse to outreach does not establish agreement with an allegation.^{15, 20, 22, 32}

No public evidence identified establishing Morgan Stanley’s inclusion in the reviewed OHCHR settlement database or a company-specific finding in A/HRC/59/23. The sovereign-debt relationship is documented, but financial participation alone does not establish ideological endorsement, individual knowledge or legal culpability. The fixed political inputs remain I=2.0, M=0.0, P=0.0, producing Political=0.00.^{6, 14, 33}

Named Entities and Evidence Map

Complicity Index Score

Method: V6.6. Fixed, human-vetted scores.

• V_MAX: 8.00 Avg_OTHERS: 0.00
• BRS Score: 667 Tier: B (Severe Complicity)

Economic supplies V_MAX through documented capital raising, announced sovereign-market participation and reported investment exposure, with transaction scale and direct issuer relationships distinguished from unresolved holdings attribution.^{1, 3, 4, 6, 18} The other domain scores remain zero, including Political despite its nonzero Impact input; the supplied result is 667, Tier B, without additional numerical rationale being inferred. The method is scale-free, evidence-only and human-vetted: activity type, scale and directness are assessed separately, and the fixed values are retained without recalculation.

Methodology Note

• This dossier compiles only the four supplied domain audits. Sources distinguish corporate disclosures, transaction records, public reporting, institutional-holdings reconstructions and IRS-derived grant records; unresolved findings retain their caveats.
• Under the scale-free method, Impact concerns activity type, M concerns scale and P concerns directness. Corporate size or the absolute value of a managed position does not independently establish investment intent.
• Temporal attribution distinguishes completed transactions, continuing exposure and announced arrangements awaiting operational confirmation. Divested or exited operations are mitigated; absence of a cessation announcement does not prove an ongoing underwriting obligation.
• Entity attribution excludes transitive guilt. Managed funds, subsidiaries, directors’ outside roles, shareholder businesses and MS GIFT are attributed separately unless evidence establishes a target-company act.
• A verified settlement operation would be considered in both Economic and Political. No public evidence identified establishing such a Morgan Stanley operation in the reviewed record.
• “No public evidence identified” records a negative research finding within the audits’ scope, not proof of universal absence. Allegations, formal communications and nonresponse records are not treated as judicial findings.